Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Alpha Lozenges for Chronic Cough in COPD or IPF
NCT00690885Phase 2Terminated
- Sponsor
- Ainos, Inc.
- Start
- Jun 2008
- Primary completion
- Apr 2012
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic cough comparing Interferon-alpha with Placebo (2 arms). Primary endpoints: Frequency of Cough at 4 weeks and Severity of Cough. Started Jun 2008; status: terminated.
02
Drugs
interferon alfa
03
Conditions
chronic cough
Beyond the preview
Go deeper on NCT00690885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00690885.